Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
about
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporterFacilitation of glutamate receptors enhances memoryPiracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicityGlutamate receptor ion channels: structure, regulation, and function"Messing with the mind": evolutionary challenges to human brain augmentationMember of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures.Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576.The NMDA receptor as a target for cognitive enhancementNovel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.Mechanisms shaping fast excitatory postsynaptic currents in the central nervous system.Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.Reevaluating the constraints on hypotheses regarding LTP expression.Channel gating kinetics and synaptic efficacy: a hypothesis for expression of long-term potentiationFunctional kainate-selective glutamate receptors in cultured hippocampal neurons.A novel class of allosteric modulators of AMPA/Kainate receptors.Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus.Variations in synaptic plasticity and types of memory in corticohippocampal networks.Synthesis, crystal structure and anti-fatigue effects of some benzamide derivatives.Receptor-receptor interactions as an integrative mechanism in nerve cells.Receptor changes and LTP: an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors.Evidence that changes in spine neck resistance are not responsible for expression of LTP.Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices.Long-term potentiation alters the modulator pharmacology of AMPA-type glutamate receptors.Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons.Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus.Nootropic agents enhance the recruitment of fast GABAA inhibition in rat neocortex.The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat.AMPA receptor activation and phosphatase inhibition affect neonatal rat respiratory rhythm generation.Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators.LTP changes the waveform of synaptic responses.Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects.Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors.Aniracetam improves behavioural responses and facilitates signal transduction in the rat brain.Nefiracetam (DM-9384) preserves hippocampal neural cell adhesion molecule-mediated memory consolidation processes during scopolamine disruption of passive avoidance training in the rat.Characterization of l-2-Amino-4-Phosphonobutanoate Action Following Sensitization by Quisqualate in Rat Hippocampal Slice Cultures.Comparative antagonism of kainate-activated kainate and AMPA receptors in hippocampal neurons.
P2860
Q24555193-52190381-4081-45C2-91FA-9CE1E72C408DQ24561847-4FCA701F-0123-411C-B1AF-262486E39C32Q24611731-F761384B-EB44-4C6E-829F-6BC5AEA195C9Q24685022-EEADCA53-DB54-4550-8CFE-4207B1BA0148Q28290774-9F9718CD-E85A-4690-87A9-C59AA88F7627Q28655245-A0F2CC6C-056E-4450-8327-C0B2AA4F0D39Q33938334-94247794-9EA7-4551-B03E-D188BA946030Q33970238-7CFA71D2-2A3F-4B40-941F-1CB9D4B81AC0Q34190402-F3D5EEDA-9F47-4FA0-8630-A018220FCE6FQ34288139-57156630-FD92-4A71-AE10-67D6B2698A58Q34348499-D4F59F27-BC67-4E62-AB3D-AA9D1FD2990FQ34465317-06F1F134-05E8-490A-88AF-A7B65CB12A71Q35379102-F335FEA3-680F-4B78-9EA7-6BED36F2DF71Q36476271-39B7FB38-4B31-4541-B00F-77F5FB9E8145Q36496886-2D5E65BF-347A-4B2A-A7B1-8032CBDE494FQ36721527-620D00BC-6749-450D-BF47-F4E9844D195CQ37130013-28333B8B-C888-4C32-B9C2-2B9A5D8FBE38Q37345192-47AA4429-BE2A-47A9-BF66-57D80214A280Q37638539-789BC318-09C4-49C2-8F52-279BD80945FDQ38130536-A8D30B5A-793F-4814-BC05-9036100E43F1Q39268965-4A426836-8B67-4EFB-AEA9-FC40F714735DQ40388833-98F67552-854A-491E-8A19-B6A6174CACE8Q41088039-8B9295BF-51D9-47FE-BC49-2E41389FCD6EQ41159662-AF139A02-1DD5-43A8-A195-4601376AC043Q42703440-9B23C93F-85AF-4528-A890-92D46E989CFBQ43444124-ABF7D8BE-D2AC-46D8-A9E2-87140BD963BFQ43607871-BAA69E94-A24A-4903-A309-A035761EBC1FQ43993662-47642CA1-851F-49F0-B2BC-63442374E2FFQ45086403-C8A47CBA-4D8D-4173-9DD3-1385538E2D6BQ45141096-EF7099E4-418F-4857-B3AB-965401BE2791Q45155106-F77E30D9-7476-4FD2-AD43-53FD800D8178Q45230322-43E52F33-6F10-42D3-AE23-60A2F3B9C3E8Q46020185-F939307C-A413-43CE-A0C2-6E994C8A2F93Q46067102-29D0D855-DC43-4F9B-95DD-1ADBF22BE574Q46787562-01D8816E-87D7-481E-82D8-5C2996C27BD4Q48117254-BFA03450-A33A-4CB5-A1C1-C3A21FB3824CQ48192489-83961DAB-8093-4401-BA78-8191BCB78415Q48251287-82341169-F24B-4E1F-86E1-39DFAB17D9B8Q48551882-A2CB7D54-35A2-491D-9338-48788556D6B4Q48899977-DD3200FE-6517-476F-8D63-C7D027C9C5BC
P2860
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@ast
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en-gb
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@nl
type
label
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@ast
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en-gb
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@nl
prefLabel
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@ast
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en-gb
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@nl
P2093
P2860
P1476
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam
@en
P2093
P2860
P304
P356
10.1113/JPHYSIOL.1990.SP018081
P407
P577
1990-05-01T00:00:00Z